Sat.Apr 20, 2024

article thumbnail

Parents, Coaches: Help Young Athletes Avoid Summer Heat Hazards

Drugs.com

SATURDAY, April 20, 2024 -- Another broiling summer looms, along with another season of kids' summer sports.It's a potentially harmful, even lethal combination. But experts at Nationwide Children's Hospital (NCH) have advice for kids, parents and.

Hospitals 264
article thumbnail

#ScienceSaturday: 4/20/2024

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Presynaptic perspective: Axonal transport defects in neurodevelopmental disorders When you get caught in a traffic jam, there can be any number of causes: there could be a car accident, an obstac

Disease 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Which pharmaceutical companies have the most drug patents in United Kingdom?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in United Kingdom.

article thumbnail

New tentative approval for Xiamen Lp drug topiramate

Drug Patent Watch

[!

Drugs 59
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

New patent expiration for Nalpropion drug CONTRAVE

Drug Patent Watch

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from one supplier.

Drugs 59